| Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception … D Baci, A Bruno, C Cascini, M Gallazzi, L Mortara, F Sessa, G Pelosi, ... Journal of Experimental & Clinical Cancer Research 38, 1-17, 2019 | 58 | 2019 |
| The immune landscape of osteosarcoma: implications for prognosis and treatment response C Cascini, C Chiodoni Cells 10 (7), 1668, 2021 | 41 | 2021 |
| Downregulation of pro-inflammatory and pro-angiogenic pathways in prostate cancer cells by a polyphenol-rich extract from olive mill wastewater D Baci, M Gallazzi, C Cascini, M Tramacere, D De Stefano, A Bruno, ... International journal of molecular sciences 20 (2), 307, 2019 | 41 | 2019 |
| Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma C Cascini, C Ratti, L Botti, B Parma, V Cancila, A Salvaggio, C Meazza, ... Journal of Experimental & Clinical Cancer Research 42 (1), 154, 2023 | 9 | 2023 |
| The transcription factor ZEB1 shapes osteosarcoma aggressiveness by affecting tumour cell differentiation and stemness features C Cascini The Open University, 2024 | | 2024 |
| Identification of new potential vulnerabilities for differentiation-based therapeutic strategies against osteosarcoma C Cascini, D Lecis, V Cancila, K Scotlandi, C Tripodo, MP Colombo, ... Cancer Research 84 (6_Supplement), 3349-3349, 2024 | | 2024 |
